Skip to main content

Stonnington Group, LLC

SEC CIK
0001325261
Latest filing
Apr 14, 2023

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Stonnington Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q1 2023 holdings

Shares (Q1 2023)
9,400
Value
$744.1K
% of portfolio
0.2%
Quarters held
3
Since Q2 2021
Holdings of APLS by Stonnington Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20239,400$744.1K0.2%+9,400NewHolders
Q1 20220$00.0%−10,000−100.0%Sold outHolders
Q4 202110,000$412.0K0.1%+10,000NewHolders
Q3 20210$00.0%−8,000−100.0%Sold outHolders
Q2 20218,000$524.0K0.1%+8,000NewHolders